Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD) or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

 

    Related Conference of Vaccines for Immune Mediated Diseases

    November 26-27, 2021

    33rd Annual Congress on Immunology and Vaccinations

    Vancouver, Canada
    December 01-02, 2021

    41st Global Summit and Expo on Vaccines & Immunology

    Frankfurt, Germany
    March 09-10, 2022

    6th International Conference on Vaccines and Immunology

    Geneva, Switzerland
    April 18-19, 2022

    Global Summit on Vaccines and Immunology

    Madrid, Spain
    October 07-08, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland

    Vaccines for Immune Mediated Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in